Literature DB >> 29200356

Marketplace Plans Provide Risk Protection, But Actuarial Values Overstate Realized Coverage For Most Enrollees.

Maria Polyakova1, Lynn Mei Hua2, M Kate Bundorf3.   

Abstract

The Affordable Care Act (ACA) has increased the number of Americans with health insurance. Yet many policy makers and consumers have questioned the value of Marketplace plan coverage because of the generally high levels of cost sharing. We simulated out-of-pocket spending for bronze, silver, or gold Marketplace plans (those having actuarial values of 60 percent, 70 percent, and 80 percent, respectively). We found that for the vast majority of consumers, the proportion of covered spending paid by the plans is likely to be far less than their actuarial values, the metric commonly used to convey plan generosity. Indeed, only when annual health care spending exceeds $16,500 for bronze plans, $19,500 for silver plans, and $21,500 for gold plans do plans in these metal tiers cover the proportion of costs matching their actuarial values. While Marketplace plans substantially reduce consumers' exposure to financial risk relative to being uninsured, the use of actuarial values to communicate plan generosity is likely to be misleading to consumers.

Keywords:  Insurance Coverage < Insurance; Insurance Market < Insurance

Mesh:

Year:  2017        PMID: 29200356     DOI: 10.1377/hlthaff.2017.0660

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  2 in total

1.  Analysis of Publicly Funded Reinsurance-Government Spending and Insurer Risk Exposure.

Authors:  Maria Polyakova; Vinayak Bhatia; M Kate Bundorf
Journal:  JAMA Health Forum       Date:  2021-08-13

Review 2.  Utilization Patterns of Facet Joint Interventions in Managing Spinal Pain: a Retrospective Cohort Study in the US Fee-for-Service Medicare Population.

Authors:  Laxmaiah Manchikanti; Amol Soin; Dharam P Mann; Sanjay Bakshi; Vidyasagar Pampati; Alan D Kaye; Joshua A Hirsch
Journal:  Curr Pain Headache Rep       Date:  2019-08-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.